Costs and outcomes of treatments for excessive alcohol consumption: Making policy decisions with the available data

References

• Agosti V. The efficacy of treatments in reducing alcohol consumption: A meta-analysis. International Journal of the Addictions 1995; 30(8)1067–1077
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association. Diagnostic and statistical manual of mental disorders 4th ed. American Psychiatric Association, Washington, DC 1994
   Google Scholar
• Anton R, Moak D, Waid R, Latham P, Malcolm R, Dias J. Naltrexone and cognitive behavioural therapy for the treatment of outpatient alcoholics: Results of a placebo-controlled trial. American Journal of Psychiatry 1999; 156(11)1758–1764
   PubMed Web of Science ®Google Scholar
• Apodaca TR, Miller WR. A meta-analysis of the effectiveness of bibliotherapy for alcohol problems. Journal of Clinical Psychology 2003; 59(3)289–304
   PubMed Web of Science ®Google Scholar
• Australian Institute of Health & Welfare. 2001 National Drug Strategy Household Survey: First results. AIHW, Canberra 2002, (Drug Statistics Series No. 9; AIHW Cat. No. PHE 35)
   Google Scholar
• Babor TF, Ceateoan R, Casswell S, Edwards G, Giesbrecht N, Graham K, et al. Alcohol: No ordinary commodity. Oxford University Press, Oxford, UK 2003
   Google Scholar
• Bien TH, Miller WR, Tonigan JS. Brief interventions for alcohol problems: A review. Addiction 1993; 88(3)315–336
   PubMed Web of Science ®Google Scholar
• Booth BM, Blow FC, Loveland Cook CA, Bunn JY, Fortney JC. Relationship between inpatient alcoholism treatment and longitudinal changes in healthcare utilization. Journal of Studies on Alcohol 1997; 58(6)625–637
   PubMed Web of Science ®Google Scholar
• Carroll KM. Relapse prevention as a psychosocial treatment: A review of controlled clinical trials. Experimental and Clinical Psychopharmacology 1996; 4(1)46–54
   Web of Science ®Google Scholar
• Chick J, Howlett H, Morgan MY, Ritson B. United Kingdom multicentre acamprosate study (UKMAS): A 6-month prospective study of acamprosate versus placebo in preventing relapse after withdrawal from alcohol. Alcohol and Alcoholism 2000; 35(2)176–187
   PubMed Web of Science ®Google Scholar
• Chick J, Anton R, Checinski K, Croop R, Drummond C, Farmer R, et al. A multicentre, randomized, double-blind, placebo-controlled trial of naltrexone in the treatment of alcohol dependence or abuse. Alcohol and Alcoholism 2000; 35(6)587–593
   PubMed Web of Science ®Google Scholar
• Chikritzhs T, Catalano P, Stockwell T, Donath S, Young D, Mathews S. Australian alcohol indicators, 1990–2001. National Drug Research Institute, PerthAustralia 2001
   Google Scholar
• Chisholm D, Rehm J, Van Ommeren M, Monteiro M. Reducing the global burden of hazardous alcohol use: A comparative cost-effectiveness analysis. Journal of Studies on Alcohol 2004; 65: 782–793
   PubMed Web of Science ®Google Scholar
• Collins D, Lapsley H. Counting the costs: Estimates of the social costs of drug abuse in Australia in 1998–9. Commonwealth Department of Health and Ageing, CanberraAustralia 2002
   Google Scholar
• Dawe S, Rees VW, Mattick R, Sitharthan T, Heather N. Efficacy of moderation-oriented cue exposure for problem drinkers: A randomized controlled trial. Journal of Consulting & Clinical Psychology 2002; 70(4)1045–1050
   PubMed Web of Science ®Google Scholar
• Degenhardt L, Hall W, Teesson M, Lynskey M. Alcohol use disorders in Australia: Findings from the National Survey of Mental Health and Wellbeing. National Drug and Alcohol Research Centre, SydneyAustralia 2000
   Google Scholar
• DiClemente C, Bellino L, Neavins T. Motivation for change and alcoholism treatment. Alcohol Research & Health: The Journal of the National Institute on Alcohol Abuse & Alcoholism 1999; 23(2)86
   PubMedGoogle Scholar
• Drummond MF, Sculpher MJ, Torrance GW, O’Brien BJ, Stoddart GL. Methods for the economic evaluation of healthcare programmes 3rd ed. Oxford University Press, Oxford, UK 2005
   Google Scholar
• English D, Holman C, Milne E, Winter M, Hulse G, Coddle J, et al. The quantification of drug caused morbidity and mortality in Australia 1995, ed. Australian Government Publishing Services, CanberraAustralia 1995
   Google Scholar
• Finney JW, Monahan SC. The cost-effectiveness of treatment for alcoholism: A second approximation. Journal of Studies on Alcohol 1996; 57(3)229–243
   PubMed Web of Science ®Google Scholar
• Fleming MF, Barry KL, Manwell LB, Johnson K, London R. Brief physician advice for problem alcohol drinkers: A randomized controlled trial in community-based primary care practices. Journal of the American Medical Association 1997; 277(13)1039–1045
   PubMed Web of Science ®Google Scholar
• Fox-Rushby J. Disability adjusted life years (DALYs) for decision-making? An overview of the literature. Office of Health Economics, London 2002
   Google Scholar
• Fox-Rushby J, Hanson K. Calculating and presenting disability adjusted life years (DALYs) in cost-effectiveness analysis. Health Policy and Planning 2001; 16: 326–331
   PubMed Web of Science ®Google Scholar
• Geerlings P, Ansoms C, van den Brink W. Acamprosate and prevention of relapse in alcoholics: Results of a randomized, placebo-controlled, double-blind study in out-patient alcoholics in the Netherlands, Belgium and Luxembourg. European Addiction Research 1997; 3(3)129–137
   Web of Science ®Google Scholar
• Godfrey C. Assessing the cost-effectiveness of alcohol services. Journal of Mental Health (UK) 1994; 3: 3–21
   Google Scholar
• Godfrey C. Lost productivity and costs to society. Addiction 1997; 92(Suppl. 1)S49–S54
   PubMedGoogle Scholar
• Harwood HJ, Malhotra DCV, Liui C, Chong U, Gilani J. Cost-effectiveness and cost benefit analysis of substance abuse treatment: A literature review. National Evaluation Data Services, Falls Church, VA 2002
   Google Scholar
• Hester R, Delaney H. Behavioral self-control program for Windows: Results of a controlled clinical trial. Journal of Consulting and Clinical Psychology 1997; 65(4)686–693
   PubMed Web of Science ®Google Scholar
• Heather N, Whitton B, Robertson I. Evaluation of a self-help manual for media-recruited problem drinkers: Six-month follow-up results. British Journal of Clinical Psychology 1986; 25: 19–34
   PubMed Web of Science ®Google Scholar
• Heather N, Kissoon-Singh J, Fenton G. Assisted natural recovery from alcohol problems: Effects of a self-help manual with and without supplementary telephone contact. British Journal of Addiction 1990; 85: 1177–1185
   PubMedGoogle Scholar
• Heather N, Campion PD, Neville RG, Maccabe D. Evaluation of a controlled drinking minimal intervention for problem drinkers in general practice (the DRAMS scheme). Journal of the Royal College of General Practitioners 1987; 37: 358–363
   PubMedGoogle Scholar
• Holder H, Longabaugh R, Miller WR, Rubonis AV. The cost-effectiveness of treatment for alcoholism: A first approximation. Journal of Studies on Alcohol 1991; 52(6)517–540
   PubMed Web of Science ®Google Scholar
• Holder HD, Blose JO. The reduction of healthcare costs associated with alcoholism treatment: A 14-year longitudinal study. Journal of Studies on Alcohol 1992; 53(4)293–302
   PubMed Web of Science ®Google Scholar
• Jones KR, Vischi TR. Impact of alcohol, drug abuse and mental health treatment on medical care utilization. Medical Care 1979; 17: 1–82
   PubMedGoogle Scholar
• Kranzler HR, Van Kirk J. Efficacy of naltrexone and acamprosate for alcoholism treatment: A meta-analysis. Alcoholism: Clinical & Experimental Research 2001; 25(9)1335–1341
   PubMed Web of Science ®Google Scholar
• Kranzler H, Modesta-Lowe V, Van Kirk J. Naltrexone vs. nefazodone for treatment of alcohol dependence. A placebo-controlled trial. Neuropsychopharmacology 2000; 22(5)493–503
   PubMed Web of Science ®Google Scholar
• Kreitman N. Alcohol consumption and the preventive paradox. British Journal of Addiction 1986; 81: 353–363
   PubMedGoogle Scholar
• Krystal J, Cramer J, Krol W, Kirk G, Rosenheck R. Naltrexone in the treatment of alcohol dependence. New England Journal of Medicine 2001; 345(24)1734–1739
   PubMed Web of Science ®Google Scholar
• Ladewig D, Knecht T, Leher P, Fendl A. Acamprosate, a stabilizing factor in the long-term weaning of alcohol-dependent patients. Therapeutische Umschau 1993; 50(3)182–188
   PubMedGoogle Scholar
• Latt NC, Jurd S, Houseman J, Wutzke SE. Naltrexone in alcohol dependence: A randomised controlled trial of effectiveness in a standard clinical setting. Medical Journal of Australia 2002; 176: 530–534
   PubMed Web of Science ®Google Scholar
• Ludbrook A, Godfrey C, Wyness L, Parrott S, Haw S, Napper M, et al. Effective and cost-effective measures to reduce alcohol misuse in Scotland: A literature review. Scottish Executive Health Department, EdinburghScotland 2002
   Google Scholar
• Makkai T. Patterns of drug use: Australian and the United States. Australian Government Publishing Services, CanberraAustralia 1994
   Google Scholar
• Mason BJ, Ownby RL. Acamprosate for the treatment of alcohol dependence: A review of double-blind placebo-controlled trials. CNS Spectrums 2000; 5(2)58–69
   PubMedGoogle Scholar
• McCollister KE, French MT. The relative contribution of outcome domains in the total economic benefit of addiction interventions: A review of first findings. Addiction 2003; 98: 1647–1659
   PubMed Web of Science ®Google Scholar
• Miller WR, Heather N, Hall W. Calculating standard drink units: International comparisons. British Journal of Addiction 1991; 86(1)43–47
   PubMedGoogle Scholar
• Morgenstern J, Longabaugh R. Cognitive-behavioral treatment for alcohol dependence: A review of evidence for its hypothesized mechanisms of action. Addiction 2000; 95(10)1475–1490
   PubMed Web of Science ®Google Scholar
• Mortimer D, Segal L. Economic evaluation of interventions for problem drinking and alcohol dependence: Cost per QALY estimates. Alcohol and Alcoholism 2005; 40(6)549–555
   PubMed Web of Science ®Google Scholar
• Moyer A, Finney JW, Swearingen CE, Vergen P. Brief interventions for alcohol problems: A meta-analytic review of controlled investigations in treatment-seeking and non-treatment-seeking populations. Addiction 2002; 97: 279–292
   PubMed Web of Science ®Google Scholar
• National Drug and Alcohol Research Centre. Guidelines for the treatment of alcohol problems. Commonwealth Department of Health and Ageing, SydneyAustralia 2003
   Google Scholar
• Ockene JK, Adams A, Hurley TG, Wheeler EV, Hebert JR. Brief physician- and nurse practitioner-delivered counseling for high-risk drinkers: Does it work?. Archives of Internal Medicine 1999; 159(18)2198–2205
   PubMed Web of Science ®Google Scholar
• O’Malley SS, Jaffe AJ, Chang G, Schottenfeld RS, Meyer RE, Rounsaville B. Naltrexone and coping skills therapy for alcohol dependence: A controlled study. Archives of General Psychiatry 1992; 49: 881–887
   PubMed Web of Science ®Google Scholar
• Overman GP, Teter CJ, Guthrie SK. Acamprosate for the adjunctive treatment of alcohol dependence. The Annals of Pharmacotherapy 2003; 37: 1090–1099
   PubMed Web of Science ®Google Scholar
• Pelc I, Verbanck P, Le Bon O, Gavrilovic M, Lion K, Lehert P. Efficacy and safety of acamprosate in the treatment of detoxified alcohol-dependent patients: A 90-day placebo-controlled dose-finding study. The British Journal of Psychiatry 1997; 171(7)73–77
   PubMedGoogle Scholar
• Poldrugo F. Acamprosate treatment in a long-term community-based alcohol rehabilitation programme. Addiction 1997; 92(11)1537–1546
   PubMed Web of Science ®Google Scholar
• Project MATCH Research Group. Matching alcoholism treatments to client heterogeneity: Project MATCH posttreatment drinking outcomes. Journal of Studies on Alcohol 1997; 58: 7–29
   PubMed Web of Science ®Google Scholar
• Raistrick D, Hodgson R, Ritson B. Tackling alcohol together: The evidence base for a UK alcohol policy. Free Association Books, London 1999
   Google Scholar
• Richmond RL, Kehoe L, Hailstone S, Wodak A, Uebel-Yan M. Quantitative and qualitative evaluations of brief interventions to change excessive drinking, smoking and stress in the police force. Addiction 1999; 94(10)1509–1521
   PubMed Web of Science ®Google Scholar
• Sanchez-Craig M, Davila R, Cooper G. A self-help approach for high-risk drinking: Effect of an initial assessment. Journal of Consulting & Clinical Psychology 1996; 64(4)694–700
   PubMed Web of Science ®Google Scholar
• Sanderson K, Andrews G, Corry J, Lapsley H. Using the effect size to model change in preference values from descriptive health status. Quality of Life Research 2004; 13: 1255–1264
   PubMed Web of Science ®Google Scholar
• Sass H, Soyka M, Mann K, Zieglgansberger W. Relapse prevention by acamprosate: Results from a placebo-controlled study on alcohol dependence. Archives of General Psychiatry 1996; 53: 673–680
   PubMed Web of Science ®Google Scholar
• Saxe L, Dougherty D, Esty K, Fine M. The effectiveness and costs of alcoholism treatment: Health technology case study 22. Congress of the United States Office of Technology Assessment, Washington, DC 1983
   Google Scholar
• Shanahan M, Doran C, Gibson A, Stafford J, Mattick RP. Interventions for excessive alcohol use: Costs and outcomes of pharmacotherapies and other treatments. University of New South Wales, SydneyAustralia 2005
   Google Scholar
• Shand F, Gates J, Fawcett J, Mattick R. The treatment of alcohol problems: A review of the evidence. National Alcohol Strategy, Commonwealth Department of Health and Ageing, SydneyAustralia 2003
   Google Scholar
• Sindelar JL, Jofre-Bonet M, French MT, McLellan AT. Cost-effectiveness analysis of addiction treatment: Paradoxes of multiple outcomes. Drug and Alcohol Dependence 2004; 73: 41–50
   PubMed Web of Science ®Google Scholar
• Sitharthan T, Kavanagh DJ, Sayer G. Moderating drinking by correspondence: An evaluation of a new method of intervention. Addiction 1996; 91: 345–355
   PubMed Web of Science ®Google Scholar
• Sitharthan T, Sitharthan G, Hough M, Kavanagh D. Cue exposure in moderation drinking: A comparison with cognitive-behavior therapy. Journal of Consulting and Clinical Psychology 1997; 65(5)878–882
   PubMed Web of Science ®Google Scholar
• Srisurapanont M, Jarusuraisin N. Opioid antagonists for alcohol dependence Cochrane Review, Issue 4th ed. Wiley, Chichester, UK 2003
   Google Scholar
• Tai Y, Saunders J, Celermajer D. Collateral damage from alcohol abuse: The enormous costs to Australia (letter). Medical Journal of Australia 1998; 168: 6–7
   PubMed Web of Science ®Google Scholar
• Tempesta E, Janiri L, Bignamini A, Chabac S, Potgieter A. Acamprosate and relapse prevention in the treatment of alcohol dependence: A placebo-controlled study. Alcohol and Alcoholism 2000; 35(2)202–209
   PubMed Web of Science ®Google Scholar
• Volpicelli J, Alterman A, Hayashida M, O’Brien C. Naltrexone in the treatment of alcohol dependence. Archives of General Psychiatry 1992; 49: 876–880
   PubMed Web of Science ®Google Scholar
• Volpicelli J, Rhines K, Volpicelli L, Alterman A, O’Brien C. Naltrexone and alcohol dependence. Role of subject compliance. Archives of General Psychiatry 1997; 54(8)737–742
   PubMed Web of Science ®Google Scholar
• Wallace P, Cutler S, Haines A. Randomised controlled trial of general practitioner intervention in-patients with excessive alcohol consumption: Report of a WHO Expert Committee. British Medical Journal 1988; 297: 663–668
   PubMed Web of Science ®Google Scholar
• WHO Brief Intervention Study Group. A cross-national trial of brief interventions with heavy drinkers. American Journal of Public Health 1996; 86(7)948–955
   PubMed Web of Science ®Google Scholar
• World Health Organization. Alcohol policy and the public good. Oxford University Press, New York 1995
   Google Scholar
• Young K. Alcohol misuse and violence I: The incidence and prevalence of alcohol use and violence in the Australian community. Australian Government Publishing Service, CanberraAustralia 1994
   Google Scholar